Johnson & Johnson

More

• Midday Glance: Medical Devices companies Thursday, 23 May 2013 | 1:46 PM ET

  Allergan rose$. 05 or. 1 percent, to $97.78. Baxter International Inc. fell$. 60 or. 8 percent, to $71.70. Boston Scientific Corp. rose$. 03 or. 3 percent, to $9.15.

• Midday Glance: Pharmaceuticals companies Thursday, 23 May 2013 | 1:46 PM ET

  Baxter International Inc. fell$. 60 or. 8 percent, to $71.70. Bristol-Myers Squibb Co. rose$. 36 or. 8 percent, to $46.76. Hospira fell$. 22 or. 6 percent, to $35.18.

• Alkermes posts 4Q profit as royalty payments rise Thursday, 23 May 2013 | 12:44 PM ET

  NEW YORK-- Alkermes PLC said Thursday that it was profitable in its fiscal fourth quarter as it received bigger royalty payments and more revenue for drug manufacturing. Alkermes said it earned $3 million, or 2 cents per share, over the three months ended March 31.

• UPDATE 2-New J&J anti-depressant related to "Special K" party drug Thursday, 23 May 2013 | 11:26 AM ET

  NEW BRUNSWICK, N.J., May 23- Johnson& Johnson said it plans to seek approvals for 11 new drugs by 2017, including a new type of treatment for patients with depression that have failed to benefit from standard medications.

• Early Glance: Medical Devices companies Thursday, 23 May 2013 | 10:46 AM ET

  Allergan rose$. 29 or. 3 percent, to $98.02. Baxter International Inc. fell$. 58 or. 8 percent, to $71.72. Boston Scientific Corp. fell$. 07 or. 8 percent, to $9.06.

• Early Glance: Pharmaceuticals companies Thursday, 23 May 2013 | 10:46 AM ET

  Baxter International Inc. fell$. 58 or. 8 percent, to $71.72. Bristol-Myers Squibb Co. fell$. 21 or. 5 percent, to $46.19. Hospira fell$. 26 or. 7 percent, to $35.14.

• UPDATE 1-J&J plans filing on more than 10 new drugs by 2017 Thursday, 23 May 2013 | 8:30 AM ET

  May 23- Johnson& Johnson said on Thursday it plans to submit more than 10 new products for regulatory approval by 2017, including drugs to treat hepatitis C, immune diseases and schizophrenia, and vaccines for flu, rabies and polio.

• Johnson & Johnson plans on more than 10 drugs filed by 2017 Thursday, 23 May 2013 | 7:56 AM ET

  May 23- Johnson& Johnson said on Thursday that it plans to submit more than 10 new products for regulatory approval by 2017, including drugs to treat hepatitis C, immune diseases, and schizophrenia as well as vaccines for flu, rabies and polio.

• Final Glance: Medical Devices companies Wednesday, 22 May 2013 | 6:08 PM ET

  Allergan fell$. 81 or. 8 percent, to $97.73. Baxter International Inc. fell$. 74 or 1.0 percent, to $72.30. Boston Scientific Corp. fell$. 10 or 1.1 percent, to $9.13.

• Final Glance: Pharmaceuticals companies Wednesday, 22 May 2013 | 6:08 PM ET

  Baxter International Inc. fell$. 74 or 1.0 percent, to $72.30. Bristol-Myers Squibb Co. rose $2.34 or 5.3 percent, to $46.40. Hospira fell$. 52 or 1.4 percent, to $35.40.

• Final Trade: Your First Move for Thursday, May 23 Wednesday, 22 May 2013 | 1:44 PM ET

  

  The "Fast Money" traders share their final trades of the day.

• Midday Glance: Pharmaceuticals companies Wednesday, 22 May 2013 | 1:18 PM ET

  Baxter International Inc. rose$. 16 or. 2 percent, to $73.20. Bristol-Myers Squibb Co. rose $3.30 or 7.5 percent, to $47.36. Hospira rose$. 02 or. 1 percent, to $35.94.

• Midday Glance: Medical Devices companies Wednesday, 22 May 2013 | 1:17 PM ET

  Allergan rose$. 06 or. 1 percent, to $98.60. Baxter International Inc. rose$. 16 or. 2 percent, to $73.20. St. Jude Medical Inc. fell$. 27 or. 6 percent, to $46.51.

• Midday Movers: GE, OPEN, CTRX & More Wednesday, 22 May 2013 | 1:16 PM ET

  

  Take a look at some of Wednesday's midday movers:

• Early Glance: Medical Devices companies Wednesday, 22 May 2013 | 10:51 AM ET

  Allergan rose$. 30 or. 3 percent, to $98.84. Baxter International Inc. rose$. 32 or. 4 percent, to $73.36. Boston Scientific Corp. fell$. 03 or. 3 percent, to $9.20.

• Early Glance: Pharmaceuticals companies Wednesday, 22 May 2013 | 10:51 AM ET

  Baxter International Inc. rose$. 32 or. 4 percent, to $73.36. Bristol-Myers Squibb Co. rose $2.27 or 5.2 percent, to $46.33. Hospira rose$. 21 or. 6 percent, to $36.13.

• Final Glance: Medical Devices companies Tuesday, 21 May 2013 | 8:50 PM ET

  Allergan rose$. 09 or. 1 percent, to $98.54. Baxter International Inc. rose$. 10 or. 1 percent, to $73.04. Boston Scientific Corp. fell$. 02 or. 2 percent, to $9.23.

• Final Glance: Pharmaceuticals companies Tuesday, 21 May 2013 | 8:50 PM ET

  Baxter International Inc. rose$. 10 or. 1 percent, to $73.04. Bristol-Myers Squibb Co. rose$. 30 or. 7 percent, to $44.06. Hospira fell$. 11 or. 3 percent, to $35.92.

• Midday Glance: Medical Devices companies Tuesday, 21 May 2013 | 1:16 PM ET

  Allergan fell$. 37 or. 4 percent, to $98.08. Baxter International Inc. fell$. 22 or. 3 percent, to $72.72. Boston Scientific Corp. rose$. 05 or. 5 percent, to $9.30.

• Midday Glance: Pharmaceuticals companies Tuesday, 21 May 2013 | 1:16 PM ET

  Baxter International Inc. fell$. 22 or. 3 percent, to $72.72. Bristol-Myers Squibb Co. fell$. 08 or. 2 percent, to $43.68. Hospira rose$. 12 or. 3 percent, to $36.15.